Exp Clin Endocrinol Diabetes 2001; 109(7): 365-369
DOI: 10.1055/s-2001-17408
Articles

© Johann Ambrosius Barth

Low Levels of Sex-Hormone-Binding Globulin predict insulin requirement in patients with gestational diabetes mellitus

H.-P. Kopp 1 , A. Festa 1 , W. Krugluger 2 , G. Schernthaner 1
  • 1 Department of Medicine 1, Rudolfstiftung Hospital, Vienna, Austria
  • 2 Department of Clinical Chemistry, Rudolfstiftung Hospital, Vienna, Austria
Further Information

Publication History

Publication Date:
25 September 2001 (online)

Summary:

Low Sex-Hormone-Binding Globulin (SHBG) levels - indicating a state of hyperandrogenicity - are associated with a higher risk for the development of non-insulin dependent diabetes (NIDDM) in women and are accepted as a marker of muscular insulin resistance. To analyze whether low SHBG values are also present in patients with gestational diabetes, we investigated levels of SHBG in 42 patients with gestational diabetes mellitus (GDM) in comparison with 48 pregnant women with normal glucose tolerance (NGT). Beside maternal parameters like body-mass index (BMI), HbA1c, fasting, 1- and 2-hour blood glucose and insulin concentrations, parameters of the new-borns (head-circumference, body weight, height and sex) were recorded. Maternal and neonatal variables were then related to SHBG levels. Both groups showed no differences in BMI, height, weight or age of gestation. Patients with GDM revealed significantly lower levels of SHBG than pregnant women with NGT(512 ± 249 nmol/l vs. 643 ± 137 nmol/l; p < 0.01). In patients with severe GDM and insulin therapy significantly lower levels of SHBG than in those with dietary treatment only were found (223 ± 210 nmol/l vs. 592 ± 102 nmol/l; p < 0.001). SHBG was inversely correlated to BMI (r = - 0.30; p < 0.01), 1-hour (r = - 0.20; p < 0.05) and 2-hour blood glucose levels (r = - 0.30; p <0.01). In summary, we found significantly lower levels of SHBG in patients with GDM, especially in those who developed severe GDM and required insulin therapy during the last months of pregnancy.

References

  • 1 Anderson D. Sex-Hormone-Binding Globulin.  Clinical Endocrinology. 3 69-96 1974; 
  • 2 Andersson B, Marin P, Lissner L, Vermeulen A, Björntorp P. Testosterone concentrations in women and men with NIDDM.  Diabetes Care. 17 405-410 1994; 
  • 3 Birkeland K, Hanssen K, Torjesen P, Vaaler S. Levels of Sex-Hormone-Binding Globulin is positively correlated with insulin sensitivity in men with type 2 diabetes.  J Clin Endocrin Metabol. 76 275-278 1993; 
  • 4 Burke C W, Anderson D C. Sex-Hormone-Binding Globulin is an estrogen amplifier.  Nature. 240 38 1972; 
  • 5 Carminatti H. Biosynthesis of glycogen from uridine diphosphate glucose.  Arch Biochem Biophys. 81 508-520 1959; 
  • 6 DeFronzo R, Diebert D, Hendler R M, Felig P, Soman V. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.  J Clin Invest. 63 939-946 1979; 
  • 7 DeFronzo R, Gunnarson R, Björkman O, Olsson M, Wahren J. Effect of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus.  J Clin Invest. 76 149-155 1985; 
  • 8 DeFronzo R A, Schulman R G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 131C-nuclear magnetic resonance spectroscopy.  N Engl J Med. 322 223-228 1990; 
  • 9 Evans D J, Hoffman R G, Kalkhoff R K, Kissebah A. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic abnormalities in premenopausal women.  J Clin Endorinol Metab. 57 304-310 1983; 
  • 10 Garvey T W, Maianu L, Zhu J H, Hancock J A, Golichowski A M. Multiple defects in the adipocyte glucose transporter system causes cellular insulin resistance in gestational diabetes.  Diabetes. 42 1773-1785 1993; 
  • 11 Glass A R, Klein T. Changes in maternal serum total and free androgen levels in early pregnancy: Lack of correlation with fetal sex.  Am J Obstet Gynecol. 140 656-660 1981; 
  • 12 Haffner S M, Dunn J F, Katz M S. Relationship of Sex-Hormon-Binding Globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women.  Metabolism. 41 278-284 1992; 
  • 13 Haffner S M, Karhapää P, Mykkänen L, Laakso M. Insulin resistance, body fat distribution, and sex hormones in men.  Diabetes. 43 212-219 1994; 
  • 14 Hepp K D. Richtlinien der deutschen Diabetesgesellschaft.  Med Klin. 87 447-448 1992; 
  • 15 Holmang A, Björntorp P. The effects of cortisol on insulin sensitivity in muscle.  Acta Physiol Scand. 144 425-431 1992; 
  • 16 Holmang A, Björntorp P, Brzezinska Z, Larsson B M. The effects of short-term testosterone exposure on insulin sensitivity in female rats.  Am J Physiol. 262 E 851-855 1992; 
  • 17 Holmang A, Svedberg J, Jennische E, Björntorp P. Effects of testosterone on muscle insulin sensitivity and morphology in female rats.  Am J Physiol. 259 555-560 1990; 
  • 18 Kolterman O, Gray R, Griffin J, Bernstein P, Insel J, Scarlett J, Olefsky J. Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus.  J Clin Invest. 68 957-969 1981; 
  • 19 Kühl C. Insulin secretion and insulin resistance in pregnancy and GDM - Implications for diagnosis and management.  Diabetes 40 ((Suppl 2)) 18-24 1991; 
  • 20 Landon J C, Wynn V, Samols E. The effects of anabolic steroids on blood sugar and plasma levels in man.  Metabolism. 12 924-930 1963; 
  • 21 Lindstedt G, Lundberg P, Lapidus L, Lundgren H, Bengtsson C, Björntorp P. Low Sex-Hormone-Binding Globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden.  Diabetes. 40 123-128 1991; 
  • 22 Montelongo A, Lasuncion M, Pallardo L, Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women.  Diabetes. 41 1651-1659 1992; 
  • 23 Nestler J. Editorial: Sex-Hormone-Binding Globulin: A marker for hyperinsulinemia and/or insulin resistance?.  J Endocrinol Metabol. 76 273-275 1993; 
  • 24 Peiris A, Stagner J, Plymate S, Vogel R, Heck M, Samols E. Relation of insulin secretory pulses to Sex-Hormone-Binding Globulin in normal men.  J Clin Endocrin Metabol. 76 279-281 1993; 
  • 25 Plymate S R, Leonard J M, Paulsen C A, Fariss B L, Karpas A E. Sex-Hormone-Binding Globulin changes with androgen replacement.  J Clin Endocrin Metab. 57 645-648 1983; 
  • 26 Plymate S, Matej L, Jones R, Friedl K. Inhibition of Sex-Hormone-Binding Globulin production in the human hepatoma (hep G2) cell line by insulin and prolactin.  J Clin Endocrin Metab. 67 460-464 1988; 
  • 27 Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D. Interrelation between Plasma Sex-Hormone-Binding Globulin and plasma insulin in healthy adult women: The Telecom study.  J Clin Endocrin Metabol. 76 283-287 1993; 
  • 28 Rebuffe'-Scrive M, Cullberg G, Lundberg P, Lindsted G, Björntorp P. Anthropometric variables and metabolism in polycystic ovarian disease.  Horm Metab Res. 21 391-397 1989; 
  • 29 Takeuchi T, Nishii O, Okamura T, Yaginuma T, Kawana T. Free testosterone and abortion rate in early pregnancy.  Int J Gynaecol Obstet. 43 (2) 151-156 1993; 

Hans-Peter KoppMD 

Department of Medicine I

Rudolfstiftung Hospital

Juchgasse 25

A-1030 Vienna

Austria

Phone: + 43-1-71165-2107

Fax: + 43-1-71165-2109

Email: hans-peter.kopp@kar.magwien.gv.at